Abiraterone

Post Date:
Nov 13,2014
Expiry Date:
May 12,2015
Detailed Description:
Cas No. :154229-19-3 Abiraterone is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) -- i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. Cadila Pharmaceuticals has recently started marketing Abiraterone acetate under the trade name Abretone.

Formula C24H31NO

Mol. mass 349.509 g/mol
CAS Registry Number:
154229-19-3
Synonyms:
;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;(3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol;(3b)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol;
Molecular Formula:
C₂₄H₃₁NO
Molecular Weight:
349.509
Molecular Structure:

Offter to Sell